Spanish medical technology developer Oncovision has introduced version 2.2 of its Mammi software, which is used on the company's Mammi dedicated breast PET system.
Compatible with existing PACS software, the upgrade adds new tools for optimizing the performance and workflow of Mammi systems, according to the vendor. It has received both U.S. Food and Drug Administration clearance (FDA) and the CE Mark.
